Brendan Harmon

Statistics

Publications

Citations

141

H-Index

Active since

2014

Affiliations

Copernicus Therapeutics (United States)(Current)

Northeastern University

Brendan Harmon is an author at Copernicus Therapeutics (United States) specializing in nucleic acid delivery to the central nervous system, neuroscience, and nanomedicine.

ORCID

Publications per year

2014–2018

Publications

Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease

Amirah E.-E. Aly, Brendan Harmon, Linas Padegimas et al. · Molecular Neurobiology · 2018 · 66 citations

Life Sciences, Neuroscience, Pharmacology +17

Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain

Brendan Harmon, Amirah E.-E. Aly, Linas Padegimas et al. · Gene Therapy · 2014 · 48 citations

Pharmacy, Biotechnology, Neuroscience +17

Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain

Amirah E.-E. Aly, Brendan Harmon, Linas Padegimas et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 27 citations

Pharmacy, Neurobiology, Neuroscience +17

1–3 of 3